"Rusty Hearts": Is It Time to Rethink Iron Chelation Therapies in Post-Myocardial-Infarction Setting?

Circulation: Cardiovascular Imaging

Volumn 9, Issue 10, 2016, Pages

  Dharmakumar, Rohan ^a,b  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Editorials; heart failure; hospitalization; humans; inflammation; myocardial infarction

Indexed keywords

ADVERSE OUTCOME; CARDIAC IMAGING; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MAGNETIC RESONANCE; CHELATION THERAPY; CORONARY ARTERY; EDITORIAL; EVENT FREE SURVIVAL; HEART EJECTION FRACTION; HEART INFARCTION; HEART VENTRICLE ARRHYTHMIA; HUMAN; IRON CHELATION; MICROVASCULATURE; NO REFLOW PHENOMENON; PRIORITY JOURNAL; REPERFUSION INJURY; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; SUDDEN CARDIAC DEATH; HEART FAILURE; INFARCTION;

IRON;

CHELATION THERAPY; HEART FAILURE; HUMANS; INFARCTION; IRON; MYOCARDIAL INFARCTION;

EID: 84994158358     PISSN: 19419651     EISSN: 19420080     Source Type: Journal    
DOI: 10.1161/CIRCIMAGING.116.005541     Document Type: Editorial

References (25)

1. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet. 2003;361:13-20. doi: 10.1016/ S0140-6736(03)12113-7.
2. Hombach V, Grebe O, Merkle N, Waldenmaier S, Höher M, Kochs M, Wöhrle J, Kestler HA. Sequelae of acute myocardial infarction regarding cardiac structure and function and their prognostic signifcance as assessed by magnetic resonance imaging. Eur Heart J. 2005;26:549-557. doi: 10.1093/eurheartj/ehi147.
3. Kloner RA, Ganote CE, Jennings RB. The "no-refow" phenomenon after temporary coronary occlusion in the dog. J Clin Invest. 1974;54:1496- 1508. doi: 10.1172/JCI107898.
4. Yellon DM, Hausenloy DJ. Myocardial reperfusion injury. N Engl J Med. 2007;357:1121-1135. doi: 10.1056/NEJMra071667.
5. Kim RJ, Fieno DS, Parrish TB, Harris K, Chen EL, Simonetti O, Bundy J, Finn JP, Klocke FJ, Judd RM. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation. 1999;100:1992-2002.
6. Wu KC, Zerhouni EA, Judd RM, Lugo-Olivieri CH, Barouch LA, Schulman SP, Blumenthal RS, Lima JA. Prognostic signifcance of micro-vascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction. Circulation. 1998;97:765-772.
7. van Kranenburg M, Magro M, Thiele H, de Waha S, Eitel I, Cochet A, Cottin Y, Atar D, Buser P, Wu E, Lee D, Bodi V, Klug G, Metzler B, Delewi R, Bernhardt P, Rottbauer W, Boersma E, Zijlstra F, van Geuns RJ. Prognostic value of microvascular obstruction and infarct size, as measured by CMR in STEMI patients. JACC Cardiovasc Imaging. 2014;7:930-939. doi: 10.1016/j.jcmg.2014.05.010.
8. Hamirani YS, Wong A, Kramer CM, Salerno M. Effect of microvascular obstruction and intramyocardial hemorrhage by CMR on LV remodeling and outcomes after myocardial infarction: a systematic review and meta-analysis. JACC Cardiovasc Imaging. 2014;7:940-952. doi: 10.1016/j. jcmg.2014.06.012.
9. Kumar A, Green JD, Sykes JM, Ephrat P, Carson JJ, Mitchell AJ, Wisenberg G, Friedrich MG. Detection and quantifcation of myocardial reperfusion hemorrhage using T2∗-weighted CMR. JACC Cardiovasc Imaging. 2011;4:1274-1283. doi: 10.1016/j.jcmg.2011.08.016.
10. Husser O, Monmeneu JV, Sanchis J, Nunez J, Lopez-Lereu MP, Bonanad C, Chaustre F, Gomez C, Bosch MJ, Hinarejos R, Chorro FJ, Riegger GA, Llacer A, Bodi V. Cardiovascular magnetic resonance-derived intramyocardial hemorrhage after STEMI: infuence on long-term prognosis, adverse left ventricular remodeling and relationship with microvascular obstruction. Int J Cardiol. 2013;167:2047-2054. doi: 10.1016/j.ijcard.2012.05.055.
11. Eitel I, Kubusch K, Strohm O, Desch S, Mikami Y, de Waha S, Gutberlet M, Schuler G, Friedrich MG, Thiele H. Prognostic value and determinants of a hypointense infarct core in T2-weighted cardiac magnetic resonance in acute reperfused ST-elevation-myocardial infarction. Circ Cardiovasc Imaging. 2011;4:354-362. doi: 10.1161/CIRCIMAGING.110.960500.
12. Ganame J, Messalli G, Dymarkowski S, Rademakers FE, Desmet W, Van de Werf F, Bogaert J. Impact of myocardial haemorrhage on left ventricular function and remodelling in patients with reperfused acute myocardial infarction. Eur Heart J. 2009;30:1440-1449. doi: 10.1093/eurheartj/ehp093.
13. Robbers LF, Eerenberg ES, Teunissen PF, Jansen MF, Hollander MR, Horrevoets AJ, Knaapen P, Nijveldt R, Heymans MW, Levi MM, van Rossum AC, Niessen HW, Marcu CB, Beek AM, van Royen N. Magnetic resonance imaging-defned areas of microvascular obstruction after acute myocardial infarction represent microvascular destruction and haemorrhage. Eur Heart J. 2013;34:2346-2353. doi: 10.1093/eurheartj/eht100.
14. Carrick D, Haig C, Ahmed N, McEntegart M, Petrie MC, Eteiba H, Hood S, Watkins S, Lindsay MM, Davie A, Mahrous A, Mordi I, Rauhalammi S, Sattar N, Welsh P, Radjenovic A, Ford I, Oldroyd KG, Berry C. Myocardial hemorrhage after acute reperfused ST-segment-elevation myocardial infarction: relation to microvascular obstruction and prognostic signifcance. Circ Cardiovasc Imaging. 2016;9:e004148. doi: 10.1161/ CIRCIMAGING.115.004148.
15. Mather AN, Fairbairn TA, Ball SG, Greenwood JP, Plein S. Reperfusion haemorrhage as determined by cardiovascular MRI is a predictor of adverse left ventricular remodelling and markers of late arrhythmic risk. Heart. 2011;97:453-459. doi: 10.1136/hrt.2010.202028.
16. Kali A, Kumar A, Cokic I, Tang RL, Tsaftaris SA, Friedrich MG, Dharmakumar R. Chronic manifestation of postreperfusion intramyo-cardial hemorrhage as regional iron deposition: a cardiovascular magnetic resonance study with ex vivo validation. Circ Cardiovasc Imaging. 2013;6:218-228. doi: 10.1161/CIRCIMAGING.112.000133.
17. Cokic I, Kali A, Yang HJ, Yee R, Tang R, Tighiouart M, Wang X, Jackman WS, Chugh SS, White JA, Dharmakumar R. Iron-sensitive cardiac magnetic resonance imaging for prediction of ventricular arrhythmia risk in patients with chronic myocardial infarction: early evidence. Circ Cardiovasc Imaging. 2015;8:e003642. doi: 10.1161/CIRCIMAGING.115.003642.
18. Cokic I, Kali A, Wang X, Yang HJ, Tang RL, Thajudeen A, Shehata M, Amorn AM, Liu E, Stewart B, Bennett N, Harlev D, Tsaftaris SA, Jackman WM, Chugh SS, Dharmakumar R. Iron deposition following chronic myocardial infarction as a substrate for cardiac electrical anomalies: initial fndings in a canine model. PLoS One. 2013;8:e73193. doi: 10.1371/journal.pone.0073193.
19. Kali A, Cokic I, Tang R, Dohnalkova A, Kovarik L, Yang HJ, Kumar A, Prato FS, Wood JC, Underhill D, Marban E, Dharmakumar R. Persistent microvascular obstruction culminates in the confuence of iron oxide nano-crystal formation, proinfammatory burden and adverse left ventricular remodeling in chronic myocardial infarction. Circulation: Cardiovascular Imaging. In press.
20. Frangogiannis NG. The infammatory response in myocardial injury, repair, and remodelling. Nat Rev Cardiol. 2014;11:255-265. doi: 10.1038/ nrcardio.2014.28.
21. Bulluck H, Rosmini S, Abdel-Gadir A, White SK, Bhuva AN, Treibel TA, Fontana M, Ramlall M, Hamarneh A, Sirker A, Herrey AS, Manisty C, Yellon DM, Kellman P, Moon JC, Hausenloy DJ. Residual myocardial iron following intramyocardial hemorrhage during the convalescent phase of reperfused ST-segment-elevation myocardial infarction and adverse left ventricular remodeling. Circ Cardiovasc Imaging. 2016;9:e004940. doi: 10.1161/CIRCIMAGING.116.004940.
22. Liu PP, Mason JW. Advances in the understanding of myocarditis. Circulation. 2001;104:1076-1082.
23. Abdel-Aty H, Zagrosek A, Schulz-Menger J, Taylor AJ, Messroghli D, Kumar A, Gross M, Dietz R, Friedrich MG. Delayed enhancement and T2-weighted cardiovascular magnetic resonance imaging differentiate acute from chronic myocardial infarction. Circulation. 2004;109:2411- 2416. doi: 10.1161/01.CIR.0000127428.10985.C6.
24. Lamas GA, Goertz C, Boineau R, Mark DB, Rozema T, Nahin RL, Lindblad L, Lewis EF, Drisko J, Lee KL; TACT Investigators. Effect of disodium EDTA chelation regimen on cardiovascular events in patients with previous myocardial infarction: the TACT randomized trial. JAMA. 2013;309:1241-1250. doi: 10.1001/jama.2013.2107.
25. Chan W, Taylor AJ, Ellims AH, Lefkovits L, Wong C, Kingwell BA, Natoli A, Croft KD, Mori T, Kaye DM, Dart AM, Duffy SJ. Effect of iron chelation on myocardial infarct size and oxidative stress in ST-elevation-myocardial infarction. Circ Cardiovasc Interv. 2012;5:270-278. doi: 10.1161/CIRCINTERVENTIONS.111.966226.